DE SIMONE, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 8.101
EU - Europa 4.394
AS - Asia 2.921
AF - Africa 66
OC - Oceania 12
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.511
Nazione #
US - Stati Uniti d'America 7.808
SG - Singapore 1.604
CN - Cina 1.061
IT - Italia 882
UA - Ucraina 754
SE - Svezia 693
FI - Finlandia 515
IE - Irlanda 469
DE - Germania 394
NL - Olanda 382
CA - Canada 291
GB - Regno Unito 175
VN - Vietnam 134
IN - India 60
CI - Costa d'Avorio 56
RU - Federazione Russa 47
FR - Francia 27
TR - Turchia 19
BE - Belgio 10
AU - Australia 9
CH - Svizzera 9
HK - Hong Kong 9
JP - Giappone 9
BG - Bulgaria 8
BR - Brasile 7
EU - Europa 6
AT - Austria 5
KR - Corea 5
IR - Iran 4
BD - Bangladesh 3
CL - Cile 3
EG - Egitto 3
HR - Croazia 3
ID - Indonesia 3
IL - Israele 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
RO - Romania 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
GE - Georgia 2
MA - Marocco 2
TW - Taiwan 2
AR - Argentina 1
BT - Bhutan 1
ES - Italia 1
GA - Gabon 1
HN - Honduras 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 15.511
Città #
Chandler 1.370
Singapore 1.327
Jacksonville 887
Millbury 626
Princeton 520
Amsterdam 367
Nanjing 357
Santa Clara 280
Ottawa 272
Boston 270
Ashburn 241
Wilmington 234
Naples 214
Napoli 149
Woodbridge 149
Ann Arbor 148
Dong Ket 134
Nanchang 128
Beijing 116
Houston 114
Boardman 103
Kronberg 93
Des Moines 86
Hebei 85
Shenyang 74
Jiaxing 60
Norwalk 59
Falls Church 54
Pune 53
Seattle 47
Tianjin 47
Changsha 45
Rome 35
Lawrence 30
Dublin 28
Kunming 28
Hangzhou 25
Orange 24
Redwood City 24
Washington 23
Los Angeles 20
Munich 20
Milan 19
Dallas 15
Dearborn 15
Frankfurt am Main 14
Redmond 14
Cagliari 12
Lanzhou 11
Mountain View 11
Guangzhou 10
Helsinki 10
London 10
Sant'anastasia 10
Shanghai 10
Fort Worth 9
Hong Kong 9
Tokyo 8
Toronto 8
Sofia 7
Buonabitacolo 6
Changchun 6
Fairfield 6
Islington 5
Parma 5
Salerno 5
Springfield 5
Walnut 5
Berlin 4
Buffalo 4
Chicago 4
Cologne 4
Göttingen 4
Jinan 4
New York 4
Newham 4
Pisa 4
Stella Cilento 4
Taizhou 4
Zhengzhou 4
Bergamo 3
Bethnal Green 3
Bovisio-Masciago 3
Brussels 3
Cairo 3
Casalnuovo Di Napoli 3
Caserta 3
Genk 3
Irvine 3
Lagos 3
Marano Di Napoli 3
Melfi 3
Ningbo 3
Nocera Inferiore 3
Sandston 3
Santiago 3
Sylhet 3
The Dalles 3
Torino 3
Vienna 3
Totale 9.319
Nome #
Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy. The LIFE Study. 90
Type of myocardial infarction presentation in patients with chronic kidney disease. 79
2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility 78
Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease? 77
Effects of Sibutramine-induced Weight Loss on Cardiovascular System in Obese Subjects 74
Different Normalizations for Body Size and Population Attributable Risk of Left Ventricular Hypertrophy: the MAVI Study. 71
Serial echocardiographic assessment of left ventricular mass: how blinded should readers be? 68
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. 68
Regressione del danno d’organo cardiaco con Telmisartan nello studio ONTARGET/TRASCEND. 68
Perindopril/indapamide Combination More Effective Than Enalapril in Reducing Blood Pressare and Left Ventricular Mass: the Picxel Study 67
Antiremodeling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure: Rationale and Design. 65
Evaluation of concentric Left Ventricular Geometry in Humans: Evidence for Age-Related Systematic Underestimation 65
Association of inappropriate left ventricular mass with systolic and diastolic disfunction � The HyperGEN Study 65
Coronary Flow Reserve in Patients with Hypercholesterolemia and without Coronary Heart Disease. 65
Prognostic Value of Serial Electrocardiographic Voltage and Repolarization Changes in Essential Hypertension: The HEART Survey Study. 63
Association of suboptimal blood pressure control with body size and metabolic abnormalities. 63
Association of Myocardial Energetic Efficiency with Circumferential and Longitudinal Left Ventricular Myocardial Function in Subjects with Increased Body Mass Index (the FATCOR Study) 63
Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. 62
Estimate of White-coat Effect and Arterial Stiffness 62
Left Ventricular Geometry in Children with Mild to Moderate Chronic Renal Insufficiency. 61
Achievement of target SBP without attention to decrease in DBP can increase cardiovascular morbidity in treated arterial hypertension: the Campania Salute Network registry 61
Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension 60
Association of Hemoglobin Delivery With Left Ventricular Structure and Function in Hypertensive Patients: Losartan Intervention For End Point Reduction in Hypertension Study. 59
Prevalence and Prognostic Significance of Wall-Motion Abnormalities in Adults without Clinically Recognized Cardiovascilar Disease 59
Doppler echocardiography for the assessment of left ventricular diastolic function: methodology, clinical and prognostic value 58
Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients. The Campania Salute Network 58
Left Ventricular Diastolic Dysfunction in Type I Gaucher Disease: An Echo Doppler Study. 57
Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study. 57
L'ipertrofia del ventricolo sinistro e altre modificazioni strutturali 57
[Hemodynamic adaptation in severe obesity with or without arterial hypertension] 57
Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities 56
Electrocardiographic and Echocardiographic Detection of Myocardial Infarction in Patients with Left-Ventricular Hypertrophy: the LIFE Study 56
A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation 56
Left Atrial Systolic Force and Cardiac Markers of Preclinical Disease in Hypertensive Patients: the Hypertension Genetic Epidemiology Network (HyperGEN) Study 54
Fat is bad: even in thin people? 54
Association of Blood Pressure With Blood Viscosity in American Indians. The Strong Heart Study 54
Risk factors for arterial hypertension in adults with initial optimal bloodpressure: the Strong Heart Study. 54
Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the strong heart study. 54
Should Thiazide Diuretics be Given as First Line Antihypertensive Therapy or in Addition to Other Medications? 54
Cardiovascular risk in relation to a new classification of hypertensive left ventricular geometric abnormalities. 54
Concentric or eccentric hypertrophy: how clinically relevant is the difference? 53
Clusters of Metabolic Risk Factors Predict Cardiovascular Events in Hypertension with Target-organ Damage: The LIFE Study. 53
Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy. 53
CHA2DS2-VASc score and left atrial volume dilatation synergistically predict incident atrial fibrillation in hypertension: an observational study from the Campania Salute Network registry 53
2018 ESC/ESH Guidelines for the management of arterial hypertension 53
A case of phenotypic Anderson-Fabry disease in a female patient 52
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. 51
Left Ventricular Mass Is a Predictor of Follow-Up Uncontrolled Blood Pressure in Hipertensive Patients. 51
Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study. 50
Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated framingham risk score in individuals with dyslipidemia. 50
2D Speckle Strain Immaging Identifies Depressed Left Atrial function in Hypertensive Patients with Diastolic Dysfunction 50
Utility of Thiazide Diuretics in Combination Therapy of Hypertension 49
Site-dependency of the E/e' ratio in predicting invasive left ventricular filling pressure in patients with suspected or ascertained coronary artery disease. 49
Determinants of decline of renal function in treated hypertensive patients: the Campania Salute Network 49
Allometric normalization of cardiac measures: producing better, but imperfect, accuracy. 48
State of the Heart in the Metabolic Syndrome 48
Prevalence and characteristics of true and apparent treatment resistant hypertension in the Campania Salute Network. 48
Cardiovascular ultrasound exploration contributes to predict incident atrial fibrillation in arterial hypertension: the Campania Salute Network 48
Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network) 48
Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: The Campania Salute Network 48
Acute hyperglycemia does not affect the reactivity of coronary microcirculation in humans. 47
Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy 47
Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients 47
Reduced Systolic Myocardial Function in Children with Chronic Renal Insufficiency 46
Assesment of the Interaction of Heritability of Volume Load and Left Ventricular Mass: the Hyper GEN offspring Study. 46
Metabolic risk factors and left ventricular hypertrophy. 46
Hypertensive target organ damage predicts incident diabetes mellitus. 46
Hemodynamic Corelates of Abnormal Aortic Root Dimension in an Adult Population:The Strong Heart Study. 46
Depth variation bias and interaction with gain setting in ultrasonic tissue characterization by integrated backscatter analysis 45
Improved cardiovascular diagnostic accuracy by pocket size imaging device in non cardiologic outpatients. The NaUSiCa (Naples Ultrasound Sthetoscope in Cardiology) Study. 45
Progression of atherosclerotic carotid plaque in hypertensive patients: the Campania-Salute Network 45
Atrial Dilatation Development in Hypertensive Treated Patients: The Campania-Salute Network 45
Determinants of aortic root dilatation over time in patients with essential hypertension: The Campania Salute Network 45
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE Study. 44
Effects of Nutraceuticals on Prevalence of Metabolic Syndrome and on Calculated Framingham Risk Score in Subjects with Dyslipidemia 44
Cardiac Markers of Preclinical Disease in Adolescents with the Metabolic Syndrome: The Strong Heart Study. 44
Interstitial syndrome-lung ultrasound B lines: A potential marker for pulmonary metastases? A case series 44
Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging 44
Association of Insuline Resistance with Preclinical Cardiovascular Disease in Adolescent and young Adults: the Strong Heart Study 43
Serial speckle tracking and successful post-STEMI percutaneous coronary intervention: incremental value versus visual wall motion analysis. 43
American Heart Association 43
Nonsymmetric myocardial contribution to supranormal right ventricular function in the athlete's heart: combined assessment by speckle tracking and real time three-dimensional echocardiography. 43
Development of LV hypertrophy in treated hypertensive patients: the Campania-Salute Network (CSN) 43
Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study) 42
CORONARY FLOW RESERVE IN HYPERTENSIVE PATIENTS WITH APPROPRIATE OR INAPPROPRIATE LEFT VENTRICULAR MASS. 42
Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine 42
Left ventricular mass reduction during salt depletion in arterial hypertension. 42
Clinical impact of “in-treatment” wall motion abnormalities in hypertensive atients with left ventricular hypertrophy: the LIFE Study. 42
Does Therapy With Statins Increase Risk Of Diabetes? 42
Two-Dimensional Echocardiographic Aortic Root Dimensions in Adolescents and Adults: Normal limits in Relation to Age, Body Size and Gender 42
Massa ventricolare sinistra inappropriata in bambini con insufficienza renale cronica in fase predialitica. 42
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Asymptomatic Aortic Stenosis. 41
Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population with High Prevalence of Obesity and Diabetes: The Strong Heart Study. 41
Supernormal contractility in primary hypertension without left ventricular hypertrophy 41
Pressione arteriosa sistolica, diastolica e differenziale: aspetti fisiopatologici. 41
Analisi ecocardiografica delle variazioni anatomiche e funzionali del ventricolo sinistro in corso di trattamento antiipertensivo con nicardipina 41
Cardiac markers of preclinical disease in adolescents with the metabolic syndrome: the strong heart study. 41
Statins and Incident Diabetes 41
J Cardiovasc Med - Membro 41
Transition from Hypertension to heart failure 41
Totale 5.243
Categoria #
all - tutte 74.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020793 0 0 0 0 151 21 16 11 14 33 224 323
2020/20212.201 31 150 348 175 189 374 154 13 253 127 214 173
2021/20222.578 75 20 12 20 10 53 40 108 490 114 373 1.263
2022/20233.176 592 202 59 318 385 358 8 298 460 342 129 25
2023/20241.963 72 298 246 73 106 213 31 246 17 53 425 183
2024/20252.089 724 1.003 53 153 156 0 0 0 0 0 0 0
Totale 16.044